Amundi Asset Management US’s BeOne Medicines Ltd ONC Stock Holding History

Amundi Asset Management US’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$34M	Sell	97,572 -4,843	-5%	-$1.6M	0.03%	523
2020 Q4	$26.5M	Buy	102,415 +80,064	+358%	+$22M	0.02%	554
2020 Q3	$6.4M	Buy	22,351 +2,777	+14%	+$653K	0.01%	837
2020 Q2	$3.69M	Sell	19,574 -775	-4%	-$126K	﹤0.01%	945
2020 Q1	$2.5M	Buy	20,349 +911	+5%	+$142K	﹤0.01%	904
2019 Q4	$3.22M	Buy	19,438 +937	+5%	+$156K	﹤0.01%	1019
2019 Q3	$2.27M	Sell	18,501 -1,900	-9%	-$252K	﹤0.01%	1068
2019 Q2	$2.53M	Buy	20,401 +3,400	+20%	+$432K	﹤0.01%	1097
2019 Q1	$2.24M	Buy	17,001 +1,500	+10%	+$202K	﹤0.01%	1067
2018 Q4	$2.17K	Buy	15,501 +14,601	+1,622%	+$1.94M	﹤0.01%	1027
2018 Q3	$155K	Buy	+900	New	+$151K	﹤0.01%	1477

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Amundi Asset Management US's ONC Position: Q1 2021 in Review

Amundi Asset Management US reduced its BeOne Medicines Ltd (ONC) stake by 4.7% in Q1 2021, selling an estimated $1.6M and leaving 97,572 shares worth $34M. The position accounts for 0.03% of the portfolio, ranked #523.

Amundi Asset Management US first reported a position in ONC in Q3 2018 and has held it in 11 quarters since. 252 funds tracked by Wall St. Rank hold ONC as of Q1 2021.

Amundi Asset Management US held 97,572 shares of BeOne Medicines Ltd worth $34M as of Q1 2021.
Amundi Asset Management US sold 4,843 BeOne Medicines Ltd shares in Q1 2021, an estimated $1.6M.
BeOne Medicines Ltd made up 0.03% of Amundi Asset Management US's portfolio in Q1 2021, its #523 holding.
Amundi Asset Management US first reported a position in BeOne Medicines Ltd in Q3 2018 and has held it in 11 quarters since.
252 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.